Gilead in charts: Veklury revenue plunges 60% Y/Y in Q3
Published 1 week ago
Oct 30, 2025 at 8:50 PM
Positive
Auto
[ ]
Seeking Alpha
[ ]
Seeking Alpha
[ ]
Seeking Alpha
[ ]
Seeking Alpha
[ ]
Seeking Alpha
MORE ON GILEAD SCIENCES
* What To Expect From Gilead In Q3 2025 [https://seekingalpha.com/article/4833109-what-to-expect-from-gilead-in-q3-2025]
* Gilead Sciences Breaks Out To Record Highs, The Rally Has Room To Run [https://seekingalpha.com/article/4830996-gilead-sciences-breaks-out-to-record-highs-rally-has-room-to-run]
* Gilead Sciences: Yeztugo And Trodelvy Make This A Buy Once More [https://seekingalpha.com/article/4825284-gilead-sciences-yeztugo-and-trodelvy-make-this-a-buy-once-more]
* Gilead drops despite narrowing 2025 outlook ranges on weak Veklury sales [https://seekingalpha.com/news/4511785-gilead-drops-despite-narrowing-2025-outlook-ranges-weak-veklury-sales]
* Gilead Sciences Non-GAAP EPS of $2.47 beats by $0.33, revenue of $7.77B beats by $310M [https://seekingalpha.com/news/4511708-gilead-sciences-non-gaap-eps-of-2_47-beats-by-0_33-revenue-of-7_77b-beats-by-310m]